Description

Cheiranthoside Viii CAS NO 7044-33-9 is a specific cardiac glycoside compound, a member of the cheiranthoside family, known for its distinct biological activity profile. This high-purity reference standard is critical for pharmaceutical research and development, particularly in the study of cardiac pharmacology and natural product chemistry. It serves as an essential analytical standard for quality control in botanical extract manufacturing and as a key intermediate in advanced synthetic pathways for researchers and development chemists in the life sciences sector.

Application

• Pharmaceutical Reference Standard: Used as a certified reference material (CRM) for the identification, purity assessment, and quantification of cheiranthosides in drug discovery and quality control laboratories.
• Cardiac Pharmacology Research: Employed in biochemical and cellular assays to study structure-activity relationships (SAR) and mechanisms of action related to cardiac glycoside activity.
• Natural Product Isolation & Analysis: Serves as a critical benchmark in the HPLC, LC-MS, and NMR analysis of plant extracts from species like *Cheiranthus cheiri* (wallflower) and other botanical sources.
• Academic & Institutional Research: A vital tool for universities and research institutes conducting studies on secondary plant metabolites and their potential therapeutic applications.
• Biochemical Pathway Studies: Utilized in metabolic and biosynthetic pathway research to understand the production of cardiac glycosides in plants.
• Analytical Method Development: Acts as a pure compound for developing and validating new chromatographic (HPLC, UPLC) and spectroscopic analytical methods.

Basic Information

Product Name	Cheiranthoside Viii
CAS No.	7044-33-9
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Cheiranthoside VIII; Cheiranthoside-VIII; 3-O-[β-D-Glucopyranosyl-(1→4)-6-deoxy-α-L-mannopyranosyl]strophanthidin; Strophanthidin 3-O-[β-D-glucopyranosyl-(1→4)-6-deoxy-α-L-mannopyranoside]; Cheiranthoside 8; Cardiac glycoside C.I. 8
EINECS	Contact for details

Quality Control

Every batch of Cheiranthoside Viii is produced and analyzed under strict quality management protocols to ensure identity, purity, and consistency. Our products undergo rigorous quality testing, including advanced chromatographic and spectroscopic methods, to ensure compliance with industry standards for reference materials. Certificates of Analysis (COA) detailing batch-specific results for identity, assay purity, and related substances are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a desiccated environment to maintain stability and purity. For long-term storage, consider storing under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0%
Water Content (KF)	≤ 5.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.